Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Account Payables: 2020-2025

Historic Change in Account Payables for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$1.2 million.

  • Journey Medical's Change in Account Payables fell 262.86% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year increase of 70.51%. This contributed to the annual value of -$2.1 million for FY2024, which is 88.61% up from last year.
  • Journey Medical's Change in Account Payables amounted to -$1.2 million in Q3 2025, which was up 27.45% from -$1.6 million recorded in Q2 2025.
  • Journey Medical's 5-year Change in Account Payables high stood at $23.7 million for Q3 2021, and its period low was -$11.9 million during Q2 2023.
  • For the 3-year period, Journey Medical's Change in Account Payables averaged around -$2.3 million, with its median value being -$1.6 million (2025).
  • Per our database at Business Quant, Journey Medical's Change in Account Payables soared by 736.04% in 2022 and then plummeted by 511.99% in 2023.
  • Over the past 5 years, Journey Medical's Change in Account Payables (Quarterly) stood at -$5.5 million in 2021, then spiked by 153.88% to $2.9 million in 2022, then tumbled by 440.18% to -$10.0 million in 2023, then soared by 107.10% to $711,000 in 2024, then tumbled by 262.86% to -$1.2 million in 2025.
  • Its Change in Account Payables was -$1.2 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$1.6 million in Q1 2025.